Search Within

Neil Jayendra Shah

Formats
  1. Meeting Abstract (53)
  2. Journal Article (27)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (83)
  2. Genitourinary Oncology Service (83)
  3. Solid Tumor Oncology Division (83)
  4. Hematologic Malignancies, Division of (31)
  5. Weinberg Fellows (31)
  6. Population Sciences Research Program (25)

More Groups

People
  1. Robert Motzer (37)
  2. Ritesh Kotecha (26)
  3. Martin Voss (25)
  4. Maria Carlo (22)
  5. Darren Feldman (21)
  6. Chung-Han Lee (20)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (22)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Journal for ImmunoTherapy of Cancer (7)
  3. Cancers (4)
  4. The Oncologist (3)
  5. Annals of Oncology (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (46)
  2. Biomed Central Ltd (7)
  3. Oxford University Press (6)
  4. MDPI (5)
  5. American Association for Cancer Research (3)
  6. American Medical Association (2)

More Publishers

Results (83)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Health care resource use for modern first-line treatments in metastatic renal cell carcinoma
    Journal Article

    Shah, N. J.; Shinde, R.; Moore, K. J.; Sainski-Nguyen, A.; Le, L. B.; Cao, F.; Song, R.; Singhal, P.; Motzer, R. J.
    JAMA Network Open (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Immunologic profiling of immune-related cutaneous adverse events with checkpoint inhibitors reveals polarized actionable pathways
    Journal Article

    Lacouture, M. E.; Goleva, E.; Shah, N.; Rotemberg, V.; Kraehenbuehl, L.; Ketosugbo, K. F.; Merghoub, T.; Maier, T.; Bang, A.; Gu, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in unique cohorts underrepresented in clinical trials
    Journal Article

    Shah, N. J.; Della Pia, A.; Wu, T.; Williams, A.; Weber, M.; Sinclaire, B.; Paleoudis, E. G.; Alaoui, A.; Lev-Ari, S.; Adams, S.; more...
    Cancers (2024)

    Fulltext@MSK | Save
  • Artificial intelligence-assisted cancer status detection in radiology reports
    Journal Article

    Arya, A.; Niederhausern, A.; Bahadur, N.; Shah, N. J.; Nichols, C.; Chatterjee, A.; Philip, J.
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
    Journal Article

    Kotecha, R. R.; Knezevic, A.; Arora, K.; Bandlamudi, C.; Kuo, F.; Carlo, M. I.; Fitzgerald, K. N.; Feldman, D. R.; Shah, N. J.; Reznik, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase Ib/II study of batiraxcept (BT, AVB-S6-500, an AXL pathway inhibitor) in combination with cabozantinib (cabo) in patients with advanced clear cell renal cell carcinoma (ccRCC) who failed first-line (1L) therapy
    Meeting Abstract

    Shah, N. J.; Campbell, M. T.; Mao, S.; Ornstein, M. C.; Haas, N. B.; Gao, X.; Hammers, H.; Keshava-Prasad, H.; Hoimes, C. J.; Hussain, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P.; Perini, R. F.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save